spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Vitaros 

 HSMN NewsFeed - 28 Jan 2019
Histogen Appoints Richard Pascoe as Chairman and Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 18 Jan 2017
Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Mexico
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Dec 2016
Apricus Biosciences Announces the Launch of Vitaros(R) for the Treatment of Erectile Dysfunction in Lebanon by Elis Pharmaceuticals
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 18 Nov 2016
Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 8 Nov 2016
Innovus Pharma Signs Exclusive License and Distribution Agreement with Elis Pharmaceuticals for Zestra(R) in Lebanon
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 25 Jul 2016
Apricus Biosciences Further Expands Existing Vitaros(R) Partnership with Ferring Pharmaceuticals in Europe and Asia
Biopharmaceuticals Distribution
 HSMN NewsFeed - 15 Dec 2014
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2013
Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2013
Apricus and Laboratoires Majorelle Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream Vitaros(R) in France, Monaco and Certain African Countries
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 10 Jun 2013
Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Sep 2012
Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom
Biopharmaceuticals Licensing
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.